搜索临床试验以:U3 1402
总计971个结果
-
Minoryx Therapeutics, S.L.完全的
-
University of Washington招聘中复发性套细胞淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 移植后淋巴增生性疾病 | 难治性套细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 复发性肿瘤性移植后淋巴增生性疾病 | 难治性肿瘤性移植后淋巴增生性疾病美国
-
Imperial College LondonWellcome Trust; Imperial College Healthcare NHS Trust完全的
-
Invirsa, Inc.Biomedical Advanced Research and Development Authority完全的
-
Reata, a wholly owned subsidiary of Biogen完全的局灶节段性肾小球硬化 | IgA肾病 | 常染色体显性多囊肾 | CKD 与 1 型糖尿病相关美国
-
Capricor Inc.National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); California...终止
-
Institut de Recherches Internationales ServierADIR, a Servier Group company完全的
-
Reata, a wholly owned subsidiary of Biogen终止常染色体显性多囊肾 | ADPKD美国, 西班牙, 英国, 澳大利亚, 法国, 日本, 德国, 比利时, 捷克语, 意大利
-
Invirsa, Inc.Biomedical Advanced Research and Development Authority招聘中
-
ProtalixChiesi Farmaceutici S.p.A.完全的
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
National Center for Complementary and Integrative...University of Michigan完全的
-
Immunovant Sciences GmbH终止
-
University of OxfordCrucell Holland BV; University of Birmingham; Emergent BioSolutions; Aeras完全的
-
University of BaselKantonsspital Liestal终止
-
Verrica Pharmaceuticals Inc.Cato Research; Paidion Research, Inc.; Database Integrations, Inc.; Instat services完全的
-
Alexion Pharmaceuticals完全的溶酶体酸性脂肪酶缺乏症 | 缺乏 LAL | 胆固醇酯贮积症 (CESD)法国, 英国, 美国, 加拿大, 捷克语
-
Verrica Pharmaceuticals Inc.BioClinica, Inc.; Paidion Research, Inc.; Instat Consulting, Inc.完全的
-
Cedars-Sinai Medical CenterMedical University of South Carolina完全的
-
MediBeacon招聘中
-
Institut für Klinische Krebsforschung IKF GmbH...Eli Lilly and Company; Trium Analysis Online GmbH主动,不招人
-
University of Alabama at Birmingham终止
-
Verrica Pharmaceuticals Inc.Paidion Research, Inc.; Instat Consulting, Inc.; Database Integrations, Inc.完全的
-
Biosense Webster, Inc.主动,不招人
-
Verrica Pharmaceuticals Inc.Paidion Research, Inc.; Instat Consulting, Inc.; Database Integrations, Inc.完全的
-
TG Therapeutics, Inc.终止